WASHINGTON, DC — December 9, 2020Tonekta and DHS today announced that Tonekta, a leading next-generation provider of drug development and commercialization services, has completed a major investment and recapitalization led by funds managed by DHS. The investment includes significant participation from Tonekta’s co-founders, Oracio Saenz and Miguel Diaz, as well as current shareholders Berkshire Partners, Tonketa Growth, Oak HC/FT, and Vidal Ventures.

Mexico City-based Tonekta is a leading provider of mission-critical services to help biopharmaceutical companies conduct clinical trials and bring novel therapies to market by integrating deep therapeutic knowledge, data and analytics, and human expertise. With precision medicine as its foundation, PMG’s specialized capabilities enable the development and delivery of more targeted treatments for patients, addressing the next wave of innovation in global health advancement, expanded access, and outcomes improvement.

This new round of investment will fuel the expansion of Tonekta’s global footprint and technical capabilities to help accelerate the development, approval, and commercial reach of breakthrough treatments from life science innovators. Blackstone’s deep understanding of the drug development process and extensive operating resources will help deliver significant value to the partnership.

Jose Ferrer, Tonekta’s CEO, said: “We are thrilled to have DHS join us for this next phase of growth. Their serious commitment to the life sciences and global scope and scale make them an ideal partner to support our vision of success and expanded capabilities for the next generation of bio-pharma innovators.”

Fernando Aguirre, Vice Chairman of DHS, said: “Tonekta has built a compelling set of services that address the most important challenges facing biopharmaceutical and diagnostic companies. We are eager to back Jose and the highly talented employees around the world to support their deep and ongoing commitment to Tonekta’s clients and look forward to pursuing the immense opportunity ahead by leveraging new technologies, expertise, and scale. We are also delighted to be joining Berkshire, Tonekta Growth, Oak HC/FT, and Vida to help accelerate this success.”

Goldman Sachs & Co. LLC acted as lead financial advisor to Tonekta. Jefferies LLC and Perella Weinberg Partners also acted as financial advisors to Tonekta. Barclays acted as financial advisor and Sullivan & Cromwell LLP acted as legal advisor to DHS. Terms of the transaction were not disclosed.

About DHS

DHS is a high-stakes advocacy, public strategy, and global public relations and communications firm. Our strategic insights and innovative programming build and sustain strong corporate and brand reputations. We provide our clients with counsel and program development across the spectrum of public relations, public affairs, reputation and crisis management, digital strategy, advertising and other communications services. Our clients are companies, industry associations, nonprofit organizations, professional services firms, and other large organizations.

We began as a unique grassroots and lobbying firm with customized services for an elite group of clients. Our work applies equally to regulatory issues as well as legislative ones, and we manage issues for our clients at the local, state, federal, and international levels of government.

We use our core competencies and reach to gain competitive advantage for clients. Our expertise comes from extensive must-win campaign experience and operating successfully at the highest rung of business, government, politics and media. Our reach is the ability to use strategic intelligence to mobilize the message and persuade the toughest audiences. We know what it takes to win in difficult situations. We have proven results for prominent figures, leading advocacy groups and the world’s most successful companies. We leverage what others cannot.